Glenmark Pharma Q4 Results: Net loss widens to Rs 121 crore YoY
Glenmark Pharma on Wednesday reported a net loss of Rs 121 crore in the fourth quarter ended March 31, 2024, due to declining sales in the US and exceptional items. The drugmaker reported a net loss of Rs 34.5 crore in the corresponding quarter of the previous year. Revenue was at Rs. 3063 crore as…